New shot tested to halt damage in serious kidney diseases
NCT ID NCT06983028
Summary
This study is testing an investigational drug called atacicept for several autoimmune kidney diseases, including IgA Nephropathy and Focal Segmental Glomerulosclerosis. It aims to see if weekly injections are safe and can reduce protein in the urine and help preserve kidney function. The trial will enroll about 200 participants aged 10 and older who have one of these specific conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEPHROTIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vera Therapeutics
RECRUITINGBrisbane, California, 94005, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.